Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy

BACKGROUND: Prostate cancer (PCa) is known to be suitable for hypofractionated radiotherapy due to the very low α/β ratio (about 1.5–3 Gy). However, several randomized controlled trials have not shown the superiority of hypofractionated radiotherapy over conventionally fractionated radiotherapy. Bes...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Ming, Gao, Xian-Shu, Li, Xiaoying, Ma, Mingwei, Qi, Xin, Shibamoto, Yuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932192/
https://www.ncbi.nlm.nih.gov/pubmed/35303922
http://dx.doi.org/10.1186/s13014-022-02010-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932192/
https://www.ncbi.nlm.nih.gov/pubmed/35303922
http://dx.doi.org/10.1186/s13014-022-02010-9

Ejemplares similares